SEATTLE--(BUSINESS WIRE)--Sound Pharmaceuticals (SPI) is pleased to announce that the FDA has granted its investigational new drug, SPI-1005, Breakthrough Therapy Designation (BTD) for the treatment ...
SEATTLE, December 01, 2025--(BUSINESS WIRE)--Sound Pharmaceuticals (SPI) is pleased to announce that the FDA has granted its investigational new drug, SPI-1005, Breakthrough Therapy Designation (BTD) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback